Investor Type | Firm |
Type of Fund | Corporate VC |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Education • BioTech • Businesses Solutions • Hardware (& Manufacturing) • HealthTech (& Fitness) • Material Science • Medical Devices (& Hospital Services) • Life Science • Woman Focused |
Stages | Early Stage, Seed |
Investing | Canada • Denmark |
Investment Range | €1,000,000 |
Novo Holdings is a world-leading life science investor with a focus on creating long-term value. Based in Bagsværd, Hovedstaden, Denmark, the company takes a multi-faceted approach to its investments, with activity spanning from seed stage to well-established companies within various life science sectors. Their portfolio specifically targets areas such as Software, IT and TMT, Education, BioTech, Business Solutions, Hardware and Manufacturing, HealthTech, Material Science, Medical Devices, Life Science, and sectors focusing on women. Novo Holdings emphasizes an investment thesis that centers on supporting innovative and scalable businesses. The firm brings both capital and deep domain expertise to the table, with a minimum investment threshold of €1,000,000, highlighting their commitment to meaningful engagements that are poised to drive transformative impacts in their chosen domains. As a corporate venture capital entity, Novo Holdings seeks to fuel growth from early stage to seed level, positioning itself as an instrumental partner in the development and success of enterprises that stand on the cutting edge of science and technology. The firm has cultivated a specialty in identifying and nurturing firms that align with its strategic vision, leveraging a combination of industry knowledge, financial acumen, and a global network to foster advancements in the life sciences and related fields.